IceCure Medical Ltd
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $3.4M | $3.3M | $3.2M | $3.1M | $4.1M | $3.9M | $1.6M |
| Cost of Revenue | $2.2M | $1.8M | $1.9M | $1.6M | $1.9M | $1.4M | $1.1M |
| Gross Profit | $1.2M | $1.5M | $1.3M | $1.4M | $2.2M | $2.4M | $524.0K |
| Gross Margin | 36.3% | 44.1% | 40.3% | 46.8% | 53.0% | 63.2% | 32.2% |
| Operating Expenses | |||||||
| Research & Development | $7.4M | $7.1M | $8.3M | $9.1M | $5.9M | $3.8M | $3.0M |
| SG&A Expense | $4.5M | $3.8M | $4.2M | $735.0K | $177.0K | $120.0K | $1.3M |
| Operating Income | $-15.1M | $-15.7M | $-15.6M | $-16.7M | $-9.7M | $-4.1M | $-4.8M |
| Operating Margin | -446.7% | -476.9% | -482.4% | -542.6% | -235.0% | -107.1% | -294.0% |
| Interest Expense | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — |
| Net Income | $-15.1M | $-15.3M | $-14.7M | $-17.0M | $-9.9M | $-3.7M | $-4.6M |
| Net Margin | -445.6% | -465.5% | -453.8% | -550.3% | -239.1% | -96.4% | -279.7% |
| EPS (Basic) | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 | $0.22 | $0.33 |
| EPS (Diluted) | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 | $0.22 | $0.33 |
| Shares Outstanding (Basic) | 63.6M | 50.9M | 45.6M | 37.0M | 28.5M | 17.1M | 13.6M |
| Shares Outstanding (Diluted) | 63.6M | 50.9M | 45.6M | 37.0M | 28.5M | 17.1M | 13.6M |
| Dividends Per Share | — | — | — | — | — | — | — |